News
LFCR
7.56
-2.70%
-0.21
Weekly Report: what happened at LFCR last week (1229-0102)?
Weekly Report · 4d ago
Analysts Offer Insights on Healthcare Companies: Outlook Therapeutics (OTLK) and Lifecore Biomedical (LFCR)
TipRanks · 01/02 14:30
Lifecore Biomedical: The Turnaround Is Just Getting Started
Seeking Alpha · 01/01 13:50
Weekly Report: what happened at LFCR last week (1222-1226)?
Weekly Report · 12/29/2025 10:08
KeyBanc says momentum, strategic value building at Lifecore
TipRanks · 12/29/2025 10:05
Analysts Conflicted on These Healthcare Names: Lifecore Biomedical (LFCR) and Xenon (XENE)
TipRanks · 12/29/2025 08:20
The Week That Was, The Week Ahead: Macro & Markets, Dec. 28
TipRanks · 12/28/2025 09:16
FOMC Minutes, Jobless Claims Report In Focus As 2025 Winds Down
Seeking Alpha · 12/27/2025 16:00
Weekly Report: what happened at LFCR last week (1215-1219)?
Weekly Report · 12/22/2025 10:08
Lifecore to be added to Nasdaq Biotechnology Index
TipRanks · 12/18/2025 12:05
Lifecore Biomedical Joins Nasdaq Biotech Index
Reuters · 12/18/2025 12:00
Lifecore Biomedical Shares Rise on New Pharmaceutical Customer
Dow Jones · 12/17/2025 16:54
Analysts Offer Insights on Healthcare Companies: REPRO-MED Systems (KRMD), Novan (NOVN) and Lifecore Biomedical (LFCR)
TipRanks · 12/17/2025 14:20
Lifecore signs CDMO master services agreement with pharma customer
TipRanks · 12/17/2025 12:17
Lifecore Biomedical Lands Major Global Pharma Deal to Make Injectable Drug in the US
Benzinga · 12/17/2025 12:09
Lifecore Biomedical Signs CDMO Agreement with Multinational Pharmaceutical Company
Reuters · 12/17/2025 12:01
LIFECORE BIOMEDICAL SIGNS CDMO MASTER SERVICES AGREEMENT WITH NEW LARGE MULTINATIONAL PHARMACEUTICAL CUSTOMER
Reuters · 12/17/2025 12:00
Lifecore Biomedical to Participate at J.P. Morgan Healthcare Conference
Reuters · 12/16/2025 12:01
Weekly Report: what happened at LFCR last week (1208-1212)?
Weekly Report · 12/15/2025 10:14
Weekly Report: what happened at LFCR last week (1201-1205)?
Weekly Report · 12/08/2025 10:13
More
Webull provides a variety of real-time LFCR stock news. You can receive the latest news about Lifecore Biomedical Inc through multiple platforms. This information may help you make smarter investment decisions.
About LFCR
Lifecore Biomedical, Inc. is a fully integrated contract development and manufacturing organization (CDMO). The Company designs, develops, manufactures and sells differentiated products for biomaterials markets and license technology applications to partners. The Company offers highly differentiated capabilities in the development, fill and finish of sterile, injectable-grade pharmaceutical products in syringes and vials. It is involved in the manufacture of pharmaceutical-grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a spectrum of medical conditions and procedures. The Company uses its fermentation process and aseptic formulation and filling expertise to develop HA-based products for multiple applications and to take advantage of non-HA devices and drug opportunities.